Sonio

Sonio’s mission is to improve detection, diagnosis and care of congenital malformations, thus improving parents’ journey throughout pregnancy, enabling better outcomes for the future baby, reducing liability for physicians and reducing healthcare costs.
Today, Sonio develops an AI-enabled software, used by sonographers and ob/gyns during fetal ultrasound examination to improve their diagnostic performance. Sonio’s first product, Sonio Diagnostics, is an intelligent decision tree, using only inputs from practitioners and real-time computing multiple type of data to guide towards the next most probable sign and diagnosis. We help diagnose benign anomalies as well as rare diseases. Our everyday motivation is to see our technology improve the daily routine of physicians and daily life of future moms and children all around the world.
Our team is our main asset, mixing strong expertise, complementary skills with creative, optimistic and voluntarist spirit. CEO and CSO cofounded Sonio with 3 expert obgyns from Hopital Necker and 2 datascience experts from Ecole Polytechnique. Thanks to our fundraising, we had the chance to hire an extraordinary leadership team (CTO, Business Developer, Product Manager) and work with a fantastic team of developers, UX-designers, clinical affairs and marketing experts.
In just a year, we’ve moved from a research project to an ambitious startup launched full speed to rapidly reach its first milestones: 1st product finalized and CE mark in May 2021, FDA approval and first sales in 2022, ambitious product roadmap and new R&D projects.
We believe that team matters above all things. We want to create a balanced culture, valuing operational excellence as much as commitment to our mission. We want to create a place where everybody is thrilled to come to work and succeed professionally.
Our strategy is to grow fast and become an international standard of care for prenatal diagnosis.